Anti-FOXO3 antibody (620-670) {FITC}

Clonality:	Polyclonal
Conjugation:	FITC
Isotype:	IgG
Purification:	Affinity Purified
Concentration:	0.5 µg/µl
Dilution Range:	WB: 1:500 ELISA: 1:10, 000 IP: 1:150 IHC: 1:50-1:100
Storage Instruction:	Store at-20°C for long term storage. Avoid freeze-thaw cycles.

Gene Symbol:	FOXO3
Gene ID:	2309
Uniprot ID:	FOXO3_HUMAN
Immunogen Region:	620-670
Immunogen:	Synthetic peptide taken within amino acid region 620-670 on human Forkhead box protein O3.

Tissue Specificity	Ubiquitous.
Post Translational Modifications	In the presence of survival factors such as IGF-1, phosphorylated on Thr-32 and Ser-253 by AKT1/PKB. This phosphorylated form then interacts with 14-3-3 proteins and is retained in the cytoplasm. Survival factor withdrawal induces dephosphorylation and promotes translocation to the nucleus where the dephosphorylated protein induces transcription of target genes and triggers apoptosis. Although AKT1/PKB doesn't appear to phosphorylate Ser-315 directly, it may activate other kinases that trigger phosphorylation at this residue. Phosphorylated by STK4/MST1 on Ser-209 upon oxidative stress, which leads to dissociation from YWHAB/14-3-3-beta and nuclear translocation. Phosphorylated by PIM1. Phosphorylation by AMPK leads to the activation of transcriptional activity without affecting subcellular localization. In response to metabolic stress, phosphorylated by AMPK on Ser-30 which mediates FOXO3 mitochondrial translocation. Phosphorylation by MAPKAPK5 promotes nuclear localization and DNA-binding, leading to induction of miR-34b and miR-34c expression, 2 post-transcriptional regulators of MYC that bind to the 3'UTR of MYC transcript and prevent its translation. Phosphorylated by CHUK/IKKA and IKBKB/IKKB. TNF-induced inactivation of FOXO3 requires its phosphorylation at Ser-644 by IKBKB/IKKB which promotes FOXO3 retention in the cytoplasm, polyubiquitination and ubiquitin-mediated proteasomal degradation. May be dephosphorylated by calcineurin A on Ser-299 which abolishes FOXO3 transcriptional activity. In cancer cells, ERK mediated-phosphorylation of Ser-12 is required for mitochondrial translocation of FOXO3 in response to metabolic stress or chemotherapeutic agents. Phosphorylation at Ser-253 promotes its degradation by the proteasome. Dephosphorylation at Ser-253 by protein phosphatase 2A (PPP2CA) promotes its stabilization.interaction with PPP2CA is enhanced by AMBRA1. Deacetylation by SIRT1 or SIRT2 stimulates interaction of FOXO3 with SKP2 and facilitates SCF(SKP2)-mediated FOXO3 ubiquitination and proteasomal degradation. Deacetylation by SIRT2 stimulates FOXO3-mediated transcriptional activity in response to oxidative stress. Deacetylated by SIRT3. Deacetylation by SIRT3 stimulates FOXO3-mediated mtDNA transcriptional activity in response to metabolic stress. Heavily methylated by SET9 which decreases stability, while moderately increasing transcriptional activity. The main methylation site is Lys-271. Methylation doesn't affect subcellular location. Polyubiquitinated. Ubiquitinated by a SCF complex containing SKP2, leading to proteasomal degradation. The N-terminus is cleaved following import into the mitochondrion.
Function	Transcriptional activator that recognizes and binds to the DNA sequence 5'-AGTAAATCA-3' and regulates different processes, such as apoptosis and autophagy. Acts as a positive regulator of autophagy in skeletal muscle: in starved cells, enters the nucleus following dephosphorylation and binds the promoters of autophagy genes, such as GABARAP1L, MAP1LC3B and ATG12, thereby activating their expression, resulting in proteolysis of skeletal muscle proteins. Triggers apoptosis in the absence of survival factors, including neuronal cell death upon oxidative stress. Participates in post-transcriptional regulation of MYC: following phosphorylation by MAPKAPK5, promotes induction of miR-34b and miR-34c expression, 2 post-transcriptional regulators of MYC that bind to the 3'UTR of MYC transcript and prevent its translation. In response to metabolic stress, translocates into the mitochondria where it promotes mtDNA transcription. In response to metabolic stress, translocates into the mitochondria where it promotes mtDNA transcription. Also acts as a key regulator of chondrogenic commitment of skeletal progenitor cells in response to lipid availability: when lipids levels are low, translocates to the nucleus and promotes expression of SOX9, which induces chondrogenic commitment and suppresses fatty acid oxidation. Also acts as a key regulator of regulatory T-cells (Treg) differentiation by activating expression of FOXP3.
Protein Name	Forkhead Box Protein O3 Af6q21 Protein Forkhead In Rhabdomyosarcoma-Like 1
Database Links	Reactome: R-HSA-1181150 Reactome: R-HSA-198693 Reactome: R-HSA-5674400 Reactome: R-HSA-5687128 Reactome: R-HSA-6785807 Reactome: R-HSA-8862803 Reactome: R-HSA-8952158 Reactome: R-HSA-9607240 Reactome: R-HSA-9614399 Reactome: R-HSA-9614657 Reactome: R-HSA-9615017 Reactome: R-HSA-9617629 Reactome: R-HSA-9617828 Reactome: R-HSA-9634638
Cellular Localisation	Cytoplasm Cytosol Nucleus Mitochondrion Matrix Mitochondrion Outer Membrane Peripheral Membrane Protein Cytoplasmic Side Retention In The Cytoplasm Contributes To Its Inactivation Translocates To The Nucleus Upon Oxidative Stress And In The Absence Of Survival Factors Translocates From The Cytosol To The Nucleus Following Dephosphorylation In Response To Autophagy-Inducing Stimuli Translocates In A Ampk-Dependent Manner Into The Mitochondrion In Response To Metabolic Stress Serum Deprivation Increases Localization To The Nucleus Leading To Activate Expression Of Sox9 And Subsequent Chondrogenesis
Alternative Antibody Names	Anti-Forkhead Box Protein O3 antibody Anti-Af6q21 Protein antibody Anti-Forkhead In Rhabdomyosarcoma-Like 1 antibody Anti-FOXO3 antibody Anti-FKHRL1 antibody Anti-FOXO3A antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance